However, enrichment was also seen for KMT2A-MLLT3 mouse leukemia with FLT3N676K or Kras/Ptpn11 mutations (MAF 0.39–0.59) (Supplementary Fig. 9k and Supplementary Data 18, 27). The gene discussed is KRAS; the disease is leukemia.